Keywords: Tumors (Pre-Treatment), Tumor, Glioma; SWI; ADC; Machine learning
Motivation: WHO Grade, IDH mutation and MGMT promoter methylation are important for precise diagnosis and treatment plans for diffuse glioma patients.
Goal(s): This study aimed to investigate the predictive value of radiomics features extracted from Structural MRI, ADC and SWI.
Approach: Radiomic features were extracted from T1WI, T2WI, T1CE, FLAIR, ADC and SWI. Analysis of variance F-test were used for feature selection. 11 classifiers were utilized for model establishment.
Results: For WHO Grade task, the highest AUC was 0.990; for IDH mutation task, the highest AUC was 0.947. All the constructed models failed to predict MGMT promoter methylation status efficiently.
Impact: This work will help neuro-oncologists better understand the radiological manifestation of gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords